 |
|
|
| |
Islatravir in Combination With Doravirine Maintains HIV-1 Viral Suppression Through 96 Weeks
|
| |
| |
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
J-M Molina1; Y Yazdanpanah2; A Afani Saud3; C Bettacchi4; C Chahin Anania5; SO Klopfer6; A Grandhi6; K Eves6; D Hepler6; MN Robertson6; C Hwang6; G Hanna6; T Correll6
Saint-Louis Hospital and University, Department of Infectious Diseases, Paris, France; Bichat Hospital, Paris, France; University of Chile, Santiago, Chile; North Texas Infectious Diseases Consultants, Dallas, TX, USA; Hospital Dr. Hernan Henriquez Aravena of Temuco, Temuco, Chile; Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
